PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 16, 20250 citationsOpen Access

AI-Assisted Peptide Inhibitor Design for Alpha-Synuclein Fibrils

AI-Guided Dual Strategy for Peptide Inhibitor Design Targeting Structural Polymorphs of α-Synuclein Fibrils

View Full Paper
Ask AI
Bookmark
Share

Authors

JDJingjing DuanHZHaoyu ZhangCSChuanqi Sun

Discussion

Loading...

Member takes

Overview

This research reveals an ai-guided strategy targeting alpha-synuclein polymorphs, suggesting enhanced inhibitor design.

Key Points

  • The study shows that two peptides, T1 and S1, significantly inhibit alpha-synuclein fibrillation, indicating potential for therapeutic use.
  • Inhibitory potency of the peptides corresponds to predicted interface energies, aligning structural knowledge with functionality.
  • Employing AI-assisted methodologies like ProteinMPNN and AlphaFold-Multimer, the research advances peptide inhibitor design.
  • This innovative approach highlights the integration of cryo-em data for efficient development of inhibitors against neurodegenerative diseases.

Cite This Study

Duan et al. (2025) studied this question.

synapsesocial.com/papers/68f04935e559138a1a06e2f8https://doi.org/10.1101/2025.10.10.681708
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1AI-Guided Dual Strategy for Peptide Inhibitor Design Targeting Structural Polymorphs of α-Synuclein Fibrils2025
  2. 2Rational Design of TDP-43 Derived α-Helical Peptide Inhibitors: An <i>In Silico</i> Strategy to Prevent TDP-43 Aggregation in Neurodegenerative Disorders2024 · 1 citations
  3. 3A peptide strategy for inhibiting different protein aggregation pathways2024 · 11 citations
  4. 4Direct disassembly of α-syn preformed fibrils into α-syn monomers by an all-D-peptide2025
  5. 5Inhibitor Development for α-Synuclein Fibril’s Disordered Region to Alleviate Parkinson’s Disease Pathology2024 · 35 citations